Landscape of bronchopulmonary dysplasia: from mechanisms to management

Ya Pan1, Xueli Cheng1, Feng Tang2

  • 1Department of Neonatology, Shenzhen Longhua Maternity and Child HealthCare Hospital, Shenzhen, Guangdong Province, China.

Insights

Bronchopulmonary dysplasia (BPD) in premature infants stems from complex prenatal and postnatal factors. Current treatments focus on supportive care, with a need for targeted therapies to improve long-term outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Developmental Biology

Background:

  • Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in premature infants.
  • BPD leads to significant respiratory and neurodevelopmental issues, impacting long-term health.
  • Despite advances in neonatal care, BPD remains a major cause of morbidity in extremely preterm infants.

Purpose of the Study:

  • To review current evidence on the pathophysiology, risk factors, and therapeutic strategies for BPD.
  • To synthesize findings from recent literature on BPD management.
  • To identify gaps in knowledge and future research directions for BPD.

Main Methods:

  • Comprehensive literature search of PubMed, Web of Science, and Embase.
  • Inclusion of English-language studies published up to 2025, including original studies, reviews, and meta-analyses.
  • Narrative synthesis of relevant findings on BPD pathophysiology, risk factors, and treatment.

Main Results:

  • BPD is a multifactorial disorder involving impaired alveolarization and pulmonary vascular development due to prenatal and postnatal injuries.
  • Key pathogenic pathways include oxidative stress, inflammation, dysregulated angiogenesis, and abnormal tissue repair.
  • Preventive and therapeutic strategies include lung-protective ventilation, surfactant therapy, caffeine, cautious corticosteroid use, and nutritional support, though targeted therapies are limited.

Conclusions:

  • BPD results from complex interactions between developmental immaturity and injurious exposures.
  • Improved understanding of disease mechanisms and risk stratification can enhance prevention and early intervention.
  • Future research should prioritize targeted therapies to improve short- and long-term outcomes for preterm infants with BPD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...